First Header Logo Second Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Chappell, Mark
One or more keywords matched the following items that are connected to Chappell, Mark
Item TypeName
Academic Article Acute AT(1)-receptor blockade reverses the hemodynamic and baroreflex impairment in adult sheep exposed to antenatal betamethasone.
Academic Article Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney.
Academic Article Angiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressure.
Academic Article Unraveling the glomerular RAS: one peptidase at a time.
Academic Article Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
Academic Article Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Academic Article Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Academic Article The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus.
Academic Article Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
Academic Article Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep.
Academic Article Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.
Concept Angiotensin II Type 1 Receptor Blockers
Academic Article Downregulation of apelin in the human placental chorionic villi from preeclamptic pregnancies.
Academic Article Comparison of Candesartan and Angiotensin-(1-7) Combination to Mito-TEMPO Treatment for Normalizing Blood Pressure and Sympathovagal Balance in (mREN2)27 Rats.
Search Criteria
  • Angiotensin II Type 1 Receptor Blockers